Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete

Epidemics

Volumn 2, Issue 2, 2010, Pages 80-84

  Hanage, William P ^a   Finkelstein, Jonathan A ^b   Huang, Susan S ^c   Pelton, Stephen I ^d   Stevenson, Abbie E ^d   Kleinman, Ken ^b   Hinrichsen, Virginia L ^b   Fraser, Christophe ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HARVARD PILGRIM HEALTH CARE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Infectious disease epidemiology; Nasopharyngeal carriage; Population genetics; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; HUMAN; PNEUMOCOCCAL INFECTION; POPULATION GENETICS; POPULATION STRUCTURE; PRIORITY JOURNAL; SEROTYPE; UNITED STATES; VACCINATION;

CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; FEMALE; HUMANS; INCIDENCE; INFANT; LONGITUDINAL STUDIES; MALE; MASSACHUSETTS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PROGRAM EVALUATION; REFERENCE VALUES; RISK ASSESSMENT; SAMPLING STUDIES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VACCINES, CONJUGATE;

EID: 77953614428     PISSN: 17554365     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.epidem.2010.03.005     Document Type: Article

References (23)

1. Anon. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Mortal Wkly Rep 54 (2005) 893-897
2. Brueggemann A.B., Griffiths D.T., Meats E., Peto T., Crook D.W., and Spratt B.G. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J. Infect. Dis. 187 (2003) 1424-1432
3. Byington C.L., Samore M.H., Stoddard G.J., Barlow S., Daly J., Korgenski K., Firth S., Glover D., Jensen J., Mason E.O., Shutt C.K., and Pavia A.T. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin. Infect. Dis. 41 (2005) 21-29
4. Enright M.C., and Spratt B.G. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144 Pt 11 (1998) 3049-3060
5. Eskola J., Kilpi T., Palmu A., Jokinen J., Haapakoski J., Herva E., Takala A., Kayhty H., Karma P., Kohberger R., Siber G., and Makela P.H. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N. Engl. J. Med. 344 (2001) 403-409
6. Fraser C., Hanage W.P., and Spratt B.G. Neutral microepidemic evolution of bacterial pathogens. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1968-1973
7. Ghaffar F., Barton T., Lozano J., Muniz L.S., Hicks P., Gan V., Ahmad N., and McCracken Jr. G.H. Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. Clin. Infect. Dis. 39 (2004) 930-938
8. Hanage W.P. Serotype-specific problems associated with pneumococcal conjugate vaccination. Future Microbiol. 3 (2008) 23-30
9. Hanage W.P., Auranen K., Syrjanen R., Herva E., Makela P.H., Kilpi T., and Spratt B.G. Ability of pneumococcal serotypes and clones to cause acute otitis media: implications for the prevention of otitis media by conjugate vaccines. Infect. Immun. 72 (2004) 76-81
10. Hanage W.P., Huang S.S., Lipsitch M., Bishop C.J., Godoy D., Pelton S.I., Goldstein R., Huot H., and Finkelstein J.A. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J. Infect. Dis. 195 (2007) 347-352
11. Hicks L.A., Harrison L.H., Flannery B., Hadler J.L., Schaffner W., Craig A.S., Jackson D., Thomas A., Beall B., Lynfield R., Reingold A., Farley M.M., and Whitney C.G. Increase in non-vaccine-type pneumococcal disease in the era of widespread pneumococcal conjugate vaccination, United States, 1998-2004. J. Infect. Dis. 196 (2007) 1346-1354
12. Huang S.S., Hinrichsen V.L., Stevenson A.E., Rifas-Shiman S.L., Kleinman K., Pelton S.I., Lipsitch M., Hanage W.P., Lee G.M., and Finkelstein J.A. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 124 (2009) e1-e11
13. Huang S.S., Platt R., Rifas-Shiman S.L., Pelton S.I., Goldmann D., and Finkelstein J.A. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 116 (2005) e408-e413
14. Lexau C.A., Lynfield R., Danila R., Pilishvili T., Facklam R., Farley M.M., Harrison L.H., Schaffner W., Reingold A., Bennett N.M., Hadler J., Cieslak P.R., and Whitney C.G. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. Jama 294 (2005) 2043-2051
15. Meats E., Brueggemann A.B., Enright M.C., Sleeman K., Griffiths D.T., Crook D.W., and Spratt B.G. Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae. J. Clin. Microbiol. 41 (2003) 386-392
16. Nahm M.H., Lin J., Finkelstein J.A., and Pelton S.I. Increase in the prevalence of the newly discovered pneumococcal serotype 6C in the nasopharynx after introduction of pneumococcal conjugate vaccine. J. Infect. Dis. 199 (2009) 320-325
17. Park I.H., Moore M.R., Treanor J.J., Pelton S.I., Pilishvili T., Beall B., Shelly M.A., Mahon B.E., and Nahm M.H. Differential effects of pneumococcal vaccines against serotypes 6A and 6C. J. Infect. Dis. 198 (2008) 1818-1822
18. Pelton S.I., Huot H., Finkelstein J.A., Bishop C.J., Hsu K.K., Kellenberg J., Huang S.S., Goldstein R., and Hanage W.P. Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr. Infect. Dis. J. 26 (2007) 468-472
19. Pelton S.I., Loughlin A.M., and Marchant C.D. Seven valent pneumococcal conjugate vaccine immunization in two Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates. Pediatr. Infect. Dis. J. 23 (2004) 1015-1022
20. Simpson E.H. Measurement of diversity. Nature 163 (1949)
21. Singleton R.J., Hennessy T.W., Bulkow L.R., Hammitt L.L., Zulz T., Hurlburt D.A., Butler J.C., Rudolph K., and Parkinson A. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. Jama 297 (2007) 1784-1792
22. Spratt B.G., and Greenwood B.M. Prevention of pneumococcal disease by vaccination: does serotype replacement matter?. Lancet 356 (2000) 1210-1211
23. van Selm S., van Cann L.M., Kolkman M.A., van der Zeijst B.A., and van Putten J.P. Genetic basis for the structural difference between Streptococcus pneumoniae serotype 15B and 15C capsular polysaccharides. Infect. Immun. 71 (2003) 6192-6198